In these pooled analyses, patients who received adjuvant chemotherapy showed a reduction in the risk of recurrence, with a relative benefit irrespective of recorded patient and tumor characteristics, including age, hormone receptor status, tumor size, tumor grade, histological type, and nodal status. The gene discussed is NR4A1; the disease is neoplasm.